Regulation of a ligand-mediated association-dissociation system of anthranilate synthesis in Clostridium butyricum.
The anthranilate synthetase of Clostridium butyricum is composed of two nonidentical subunits of unequal size. An enzyme complex consisting of both subunits is required for glutamine utilization in the formation of anthranilic acid. Formation of anthranilate will proceed in the presence of partially pure subunit I provided ammonia is available in place of glutamine. Partially pure subunit II neither catalyzes the formation of anthranilate nor possesses anthranilate-5-phosphoribosylpyrophosphate phosphoribosyltransferase activity. The enzyme complex is stabilized by high subunit concentrations and by the presence of glutamine. High KCl concentrations promote dissociation of the enzyme into its component subunits. The synthesis of subunits I and II is coordinately controlled with the synthesis of the enzymes mediating reactions 4 and 5 of the tryptophan pathway. When using gel filtration procedures, the molecular weights of the large (I) and small (II) subunits were estimated to be 127,000 and 15,000, respectively. Partially pure anthranilate synthetase subunits were obtained from two spontaneous mutants resistant to growth inhibition by 5-methyltryptophan. One mutant, strain mtr-8, possessed an anthranilate synthetase that was resistant to feedback inhibition by tryptophan and by three tryptophan analogues: 5-methyl-tryptophan, 4- and 5-fluorotryptophan. Reconstruction experiments carried out by using partially purified enzyme subunits obtained from wild-type, mutant mtr-8 and mutant mtr-4 cells indicate that resistance of the enzyme from mutant mtr-8 to feedback inhibition by tryptophan or its analogues was the result of an alteration in the large (I) subunit. Mutant mtr-8 incorporates [(14)C]tryptophan into cell protein at a rate comparable with wild-type cells. Mutant mtr-4 failed to incorporate significant amounts of [(14)C]tryptophan into cell protein. We conclude that strain mtr-4 is resistant to growth inhibition by 5-methyltryptophan because it fails to transport the analogue into the cell. Although mutant mtr-8 was isolated as a spontaneous mutant having two different properties (altered regulatory properties and an anthranilate synthetase with altered sensitivity to feedback inhibition), we have no direct evidence that this was the result of a single mutational event.
D000641:Ammonia / Q000378:metabolism; D000878:Anthranilate Synthase / Q000032:analysis / Q000302:isolation & purification / Q000378:metabolism*; D001426:Bacterial Proteins / Q000096:biosynthesis; D002250:Carbon Radioisotopes; D002474:Cell-Free System; D002850:Chromatography, Gel; D003013:Clostridium / Q000201:enzymology* / Q000378:metabolism; D004794:Enzyme Repression; D005246:Feedback; D005973:Glutamine / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007930:Leucine / Q000378:metabolism; D008970:Molecular Weight; D009097:Multienzyme Complexes / Q000032:analysis / Q000302:isolation & purification / Q000378:metabolism*; D009154:Mutation; D014316:Tritium; D014364:Tryptophan / Q000378:metabolism / Q000494:pharmacology; D014367:Tryptophan Synthase / Q000378:metabolism; D062367:ortho-Aminobenzoates / Q000096:biosynthesis*
D001426:Bacterial Proteins; D002250:Carbon Radioisotopes; D009097:Multienzyme Complexes; D062367:ortho-Aminobenzoates; D005973:Glutamine; D014316:Tritium; D000641:Ammonia; D014364:Tryptophan; D000878:Anthranilate Synthase; D014367:Tryptophan Synthase; D007930:Leucine